🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Implementation of Precision Medicine in High-risk Prostate Cancer

Recruitingn/aAges 18 Years - anyMaleAndreas Josefsson
NCT06687421 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Men investigated for suspected prostate cancer * Signed consent form Exclusion Criteria: * Difficulties understanding information about the study due to linguistic, cognitive or other reason
💊

What it tests

  • High-risk treatment SOC
  • Active monitoring
  • Radical prostatectomy
  • Radiotherapy
  • Androgen deprivation therapy
📍

Where

1 site
Urology, Umeå University Hospital, Region Västerbotten
Umeå, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy